Latest News

PARP inhibitor becomes new treatment option for some men with advanced prostate cancer



Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated successfully with a targeted therapy known as rucaparib, resulting in recent FDA approval.

Source link

Related posts

CGTN解説:香港特別行政区の国家安全保障法制とは何か

Newsemia

A RAVE investigation on Galactic open clusters I. Radial velocities and metallicities

Newsemia

Want To Feel Younger? Take Control And Exercise More, Research Says

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World